Showing results (311-320 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|January 12, 2001
Parkinson's disease therapy: tailoring choices for early and late disease, young and old patientsJ JankovicClinical Neuropharmacology|January 12, 2001
Adverse drug reactions to selegiline: a review of the French pharmacovigilance databaseJ L Montastruc, C Chaumerliac, K Desboeuf, et al.Clinical Neuropharmacology|January 12, 2001
Abuse, dependence, and epileptic seizures after zolpidem withdrawal: review and case reportM AragonaClinical Neuropharmacology|January 12, 2001
Combined use of risperidone and olanzapine in the treatment of patients with resistant schizophrenia: a preliminary case series reportV Lerner, B Chudakova, S Kravets, et al.Clinical Neuropharmacology|October 6, 2000
A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollisC Brefel-Courbon, M Simonetta-Moreau, C Moré, et al.Clinical Neuropharmacology|August 12, 1999
The impact of remacemide hydrochloride on levodopa concentrations in Parkinson's disease. Parkinson Study GroupClinical Neuropharmacology|August 12, 1999
Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series studyV Lerner, A Kaptsan, C Miodownik, et al.Clinical Neuropharmacology|April 18, 2001
Multiple-dose tolerability, pharmacodynamics, and pharmacokinetics of the quinolizinone hypnotic Ro 41-3696 in elderly subjectsJ Dingemanse, E Pedrazzetti, P L van GiersbergenClinical Neuropharmacology|April 18, 2001
Gabapentin-induced hypersensitivity syndromeM V Ragucci, J M CohenPageof 236